Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Virtual Reality (VR) in Decreasing Pain and Anxiety in Patients With Sickle Cell Disease (SCD)

NCT03387033 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03387033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03387033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Virtual Reality (VR) in Decreasing Pain and Anxiety in Patients With Sickle Cell Disease (SCD)
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Terminated
Start date
February 5, 2018
Completion date
April 25, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, cancer, depression, sickle cell disease, virtual reality